Austin Asset Management Co Inc Invests $315,000 in Nutex Health Inc. $NUTX

Key Points

• Austin Asset Management Co Inc has invested approximately $315,000 in Nutex Health Inc., acquiring 2,528 shares during the second quarter.
• Analysts have varying ratings on Nutex Health, with Wall Street Zen upgrading the stock from "hold" to "strong-buy" and Maxim Group setting a price target of $205.00.
• Nutex Health's shares have seen a 12-month low of $17.66 and a high of $184.27, currently trading at approximately $102.74.

Austin Asset Management Co Inc purchased a new stake in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 2,528 shares of the company's stock, valued at approximately $315,000.

Other hedge funds have also recently made changes to their positions in the company. KLP Kapitalforvaltning AS purchased a new position in shares of Nutex Health during the 2nd quarter valued at $112,000. Bank of America Corp DE grew its position in shares of Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after purchasing an additional 2,043 shares in the last quarter. Clear Creek Financial Management LLC purchased a new position in shares of Nutex Health during the 2nd quarter valued at $397,000. Millennium Management LLC purchased a new position in shares of Nutex Health during the 4th quarter valued at $213,000. Finally, OMERS ADMINISTRATION Corp grew its position in shares of Nutex Health by 28.8% during the 1st quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company's stock valued at $442,000 after purchasing an additional 2,100 shares in the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently issued reports on NUTX shares. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Nutex Health in a report on Wednesday. Wall Street Zen raised shares of Nutex Health from a "hold" rating to a "strong-buy" rating in a report on Friday, September 26th. Finally, Maxim Group set a $205.00 price objective on shares of Nutex Health and gave the stock a "buy" rating in a report on Tuesday, August 26th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $252.50.

Nutex Health Stock Performance

Shares of NASDAQ:NUTX opened at $102.74 on Thursday. The company has a market cap of $570.72 million, a price-to-earnings ratio of 8.64 and a beta of -0.20. The company has a 50-day moving average price of $93.88 and a 200-day moving average price of $110.84. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02. Nutex Health Inc. has a 12 month low of $17.66 and a 12 month high of $184.27.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.